Treatment Choices for Improving Adherence and Outcome
NCT00194948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2013-11-04
Summary
This study will determine the effectiveness of offering primary care patients their preferred treatment versus one that is less desirable in improving treatment adherence and outcome.
Conditions
Interventions
- DRUG
-
escitalopram
- BEHAVIORAL
-
interpersonal psychotherapy
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Weill Medical College of Cornell University
lead OTHER
Principal Investigators
-
Patrick J Raue, PhD · Weill Medical College of Cornell University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2007-04-30
- Completion
- 2007-05-31
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
NCT00109044 ·Status: COMPLETED ·Phase: PHASE3
-
Aging Brain Changes, Executive Dysfunction and Depression
NCT00918684 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Depression in Adults
NCT00073697 ·Status: COMPLETED ·Phase: PHASE4
-
Identifying Factors That Predict Antidepressant Treatment Response
NCT00360399 ·Status: COMPLETED ·Phase: NA
-
Escitalopram in Adult Patients With Major Depressive Disorder
NCT00668525 ·Status: COMPLETED ·Phase: PHASE3
-
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
NCT02724735 ·Status: UNKNOWN
-
Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
NCT00239954 ·Status: UNKNOWN ·Phase: PHASE3
-
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
NCT00593879 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Antidepressant Non-Response in Late-Life Depression
NCT01931202 ·Status: COMPLETED ·Phase: NA
-
A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication
NCT04937829 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
NCT01034995 ·Status: COMPLETED ·Phase: PHASE2
-
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
NCT00000375 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
NCT00035282 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
NCT00070694 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging Predictors of Treatment Response in Depression
NCT00367341 ·Status: COMPLETED ·Phase: NA
-
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
NCT00810069 ·Status: COMPLETED ·Phase: PHASE4
-
Neurotrophic Factors and Depression
NCT00812994 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
NCT00375843 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
NCT00035295 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)
NCT00035048 ·Status: COMPLETED ·Phase: PHASE3
-
Combining Medications to Enhance Depression Outcomes
NCT00590863 ·Status: COMPLETED ·Phase: PHASE4
-
Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
NCT01894815 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Response of Geriatric Depression
NCT00754936 ·Status: COMPLETED ·Phase: NA
-
Dichotic Listening as a Predictor of Medication Response in Depression
NCT00404755 ·Status: COMPLETED ·Phase: PHASE4